Log in with your email address username.


[Comment] An anticoagulant too good to be true for revascularisation

Revascularisation is recommended for most patients presenting with acute coronary syndromes,1,2 with percutaneous coronary intervention the most common procedure. Besides dual antiplatelet treatment with aspirin and a platelet P2Y12 blocker (eg, clopidogrel, prasugrel, or ticagrelor), parenteral anticoagulation is mandatory in patients undergoing this procedure. Heparin, low-molecular-weight heparin, and the specific thrombin (factor II) blocker bivalirudin are currently used for anticoagulation.